Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
| Current Price | ₹705.20 |
|---|---|
| Market Cap | ₹405 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | -271 |
| Return on Equity | -0.38% |
| 52-Week Range | ₹579.90 – ₹957.50 |
| Beta (1Y) | 0.85 |
| Dividend Yield | 0.70% |
1. Manufacturing of Pharmaceutical Products-100%
Albert David Ltd. is trading at ₹705.20, with a market capitalisation of ₹405 Cr.
Albert David Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Albert David Ltd. has a P/E of -271 and a return on equity of -0.38%.